lisdexamfetamine_dimesylate  - Drug Details
📊 Estimates lisdexamfetamine_dimesylate  Dialyzability By Different_Modalities

lisdexamfetamine_dimesylate 

Complete Drug Information

Drug Name
lisdexamfetamine_dimesylate 
Trade Names
Vyvanse, Elvanse, Tyvense
Pregnancy Category
AU: B3
Bioavailability
Oral: 96.4%
Routes of Administration
Oral
Protein Binding
20% (as dextroamphetamine)%
Metabolism
Hydrolysis by enzymes in red blood cells initially, subsequent metabolism follows
Elimination
Lisdexamfetamine: <1 hourDextroamphetamine: 10–12 h
Excretion
Kidney: ~2% as Lisdexamfetamine and ~42% as Dextroamphetamine
Formula
C15H25N3O
Molar Mass
263.385
Onset of Action
<2 hours
Duration of Action
10–14 hours
Drug Class
Norepinephrine–dopamine releasing agent; Stimulant
Volume of Distribution
C15H25N3O

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.